Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Healthcare Medical Devices
Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight Announces Final CMS Hospital Outpatient Payment Rate for 2017 and Two New CPT Codes for Programming the Argus II Retinal Prosthesis System

Business Wire November 2, 2016

Second Sight to Discuss Third Quarter 2016 Financial Results on November 2, 2016 Conference Call

Business Wire October 26, 2016

Mid-Afternoon Market Update: Crane Rises On Upbeat Earnings; Dipexium Shares Fall

Benzinga.com  October 25, 2016

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  October 25, 2016

Second Sight Announces Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject

PR Newswire Europe Non Regulatory October 25, 2016

Second Sight to Present at The MicroCap Conference on October 25, 2016

Accesswire October 13, 2016

Healthcare Stocks Technical Reports -- Abbott Laboratories, Boston Scientific, Perrigo, and Second Sight Medical

PR Newswire October 13, 2016

Second Sight to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016

Business Wire September 2, 2016

Second Sight Reports Second Quarter 2016 Financial Results

Business Wire July 28, 2016

Second Sight Announces Two Exclusive Distribution Agreements to Bring the Argus II Retinal Prosthesis to Taiwan and Iran

Business Wire July 28, 2016

Second Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System

PR Newswire Europe Non Regulatory July 25, 2016

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  July 22, 2016

Second Sight to Discuss Second Quarter 2016 Financial Results on July 28, 2016 Conference Call

Business Wire July 21, 2016

Second Sight Announces Positive Five-Year Data from Argus II Retinal Prosthesis System

PR Newswire Europe Non Regulatory July 21, 2016

Second Sight Announces CMS Establishes Proposed Medicare Outpatient Rate for Argus II of $150K

Benzinga.com  July 7, 2016

Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering

Business Wire June 1, 2016

Second Sight Files S-1 Registration Statement for Rights Offering to Shareholders and Sets Record Date

Business Wire May 9, 2016

Second Sight Reports First Quarter 2016 Financial Results

Business Wire April 28, 2016

Second Sight to Discuss First Quarter 2016 Financial Results on April 28, 2016 Conference Call

Business Wire April 20, 2016

Second Sight: NHS England Issues Public Policy Consultation on UK Government Funding of the Argus® II Bionic Eye

PR Newswire April 6, 2016